- Home
- Publications
- Publication Search
- Publication Details
Title
Investigations of Interferon-Lambda for the Treatment of Cancer
Authors
Keywords
-
Journal
Journal of Innate Immunity
Volume 7, Issue 3, Pages 243-250
Publisher
S. Karger AG
Online
2015-02-09
DOI
10.1159/000370113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Important Role for Type III Interferon (IFN- /IL-28) in TLR-Induced Antiviral Activity
- (2014) N. Ank et al. JOURNAL OF IMMUNOLOGY
- Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)
- (2014) Rodolfo Passalacqua et al. JOURNAL OF IMMUNOTHERAPY
- Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women
- (2014) Fabiana Cannella et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Epigenetic Reprogramming of the Type III Interferon Response Potentiates Antiviral Activity and Suppresses Tumor Growth
- (2014) Siyuan Ding et al. PLOS BIOLOGY
- Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon
- (2013) Lucio Boglione et al. ANTIVIRAL RESEARCH
- Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
- (2013) María A Jiménez-Sousa et al. BMC Medicine
- Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress
- (2013) Lei Zhang et al. CANCER LETTERS
- Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10
- (2013) Christoph Burkart et al. EMBO Molecular Medicine
- Biological Rationale and Clinical Use of Interferon in the Classical BCR-ABL-Negative Myeloproliferative Neoplasms
- (2013) Brady L. Stein et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
- (2013) Charles G. Drake et al. Nature Reviews Clinical Oncology
- Interferon-Alpha in the Treatment of Multiple Myeloma
- (2012) Khoo CURRENT DRUG TARGETS
- The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma
- (2012) S. Pasquali et al. CURRENT MEDICINAL CHEMISTRY
- Potential anti-tumor effect of IFN-?2 (IL-28A) against human lung cancer cells
- (2012) Yasuhiro Tezuka et al. LUNG CANCER
- Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects
- (2011) Q Li et al. BRITISH JOURNAL OF CANCER
- Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer
- (2011) Hitomi Fujie et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A Possible Anticancer Agent, Type III Interferon, Activates Cell Death Pathways and Produces Antitumor Effects
- (2011) Masatoshi Tagawa et al. Clinical & Developmental Immunology
- Interferon Lambda: A New Sword in Cancer Immunotherapy
- (2011) Ahmed Lasfar et al. Clinical & Developmental Immunology
- IFN-α and IFN-λ differ in their antiproliferative effects and duration of JAK/STAT signaling activity
- (2010) Stephen G. Maher et al. CANCER BIOLOGY & THERAPY
- Antitumor activity of Type I and Type III interferons in BNL hepatoma model
- (2010) Walid Abushahba et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer
- (2010) Phonphimon Wongthida et al. CANCER RESEARCH
- Interferon-Lambda as a Potential Therapeutic Agent in Cancer Treatment
- (2010) Håkan C. Steen et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Interleukin-29 Binds to Melanoma Cells Inducing Jak-STAT Signal Transduction and Apoptosis
- (2010) K. D. Guenterberg et al. MOLECULAR CANCER THERAPEUTICS
- IFN- 1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells
- (2009) J. Dai et al. BLOOD
- Interferon-λ induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents
- (2009) Quanhai Li et al. EUROPEAN JOURNAL OF CANCER
- Despite IFN-λ receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines
- (2009) K Witte et al. GENES AND IMMUNITY
- Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family
- (2009) Hans Henrik Gad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of apoptosis by type III interferons
- (2008) W. Li et al. CELL PROLIFERATION
- Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes
- (2008) Kerstin Wolk et al. JOURNAL OF LEUKOCYTE BIOLOGY
- IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo
- (2008) Caroline Sommereyns et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now